World Economic Forum: women’s health gets only 20% of R&D funding. We must seize this $1 trillion opportunity
The World Economic Forum highlights significant disparities in research and development funding for women's health, which receives only 20% of health R&D resources. This underfunding affects the ability to address critical health issues that disproportionately impact women, ultimately limiting broader economic and social benefits. The newly launched Women's Health Innovation Radar aims to map these gaps and promote equitable innovation in women's health to unlock a potential $1 trillion opportunity by 2040.
- ▪Only one-fifth of all health R&D funding is allocated to women's health conditions.
- ▪More than half of the available funding is concentrated in ovarian cancer and menopause, leaving other conditions underfunded.
- ▪Fewer than 2%–3% of clinical trials focus specifically on women, leading to a lack of understanding of how diseases affect women differently.
Opening excerpt (first ~120 words) tap to expand
We live in an era of fast-moving, interconnected crises — from antimicrobial resistance and climate-related health threats to pandemics. Yet, many health systems remain ill-equipped to respond, while also struggling with aging populations, workforce constraints, and the growing pressure to adapt to increasingly complex and rapidly changing conditions.Recommended Video To address systemic flaws, as well as current and future challenges, more agile and resilient health systems are required — and innovation is vital. Investing in innovation throughout the value chain strengthens not only health outcomes, but also wider resilience and broader economic stability, national security, and sustainable growth.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fortune.
Discussion
0 commentsMore from Fortune
